HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark C Bagley Selected Research

Mark C Bagley Research Topics

Disease

14Werner Syndrome (Werner's Syndrome)
04/2016 - 11/2006
2Genomic Instability
06/2010 - 04/2007
1COVID-19
01/2022
1Neoplasms (Cancer)
03/2021
1Adenocarcinoma
03/2021
1Breast Neoplasms (Breast Cancer)
03/2021
1Autoimmune Diseases (Autoimmune Disease)
12/2020
1Polymorphic catecholergic ventricular tachycardia
01/2016

Drug/Important Bio-Agent (IBA)

10p38 Mitogen-Activated Protein KinasesIBA
12/2020 - 09/2007
6SB 203580IBA
01/2016 - 04/2007
5Phosphotransferases (Kinase)IBA
12/2011 - 04/2007
45- amino- 1- (4- fluorophenyl)- 4- (3- (2,3- dihydroxypropoxy)benzoyl)pyrazoleIBA
01/2016 - 07/2008
3KetonesIBA
01/2016 - 07/2008
3VX-745IBA
09/2010 - 11/2009
2MAP-kinase-activated kinase 2IBA
06/2015 - 01/2013
2doramapimodIBA
06/2010 - 11/2006
1Leflunomide (Arava)FDA LinkGeneric
01/2022
1teriflunomideIBA
01/2022
1Antirheumatic Agents (DMARD)IBA
01/2022
1Molecular Chaperones (Chaperone, Molecular)IBA
03/2021
1carbazoleIBA
03/2021
1Histones (Histone)IBA
03/2021
1CarbazolesIBA
03/2021
1Flecainide (Tambocor)FDA LinkGeneric
01/2016
13-pyridinylboronic acidIBA
06/2015
12-chloroquinolineIBA
06/2015
1AcidsIBA
06/2015
1BromidesIBA
06/2015
1Adenosine Triphosphate (ATP)IBA
09/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2010
1Therapeutic UsesIBA
02/2010
1VX (EDIM)IBA
09/2007
1Mitogen-Activated Protein Kinase 14IBA
11/2006
1CarbamatesIBA
11/2006
1pyrazoleIBA
11/2006
1Urea (Carbamide)FDA LinkGeneric
11/2006

Therapy/Procedure

1Therapeutics
12/2011